COMP <GO>
ULBI vs CHPT // PIOTROSKI F-SCORE QUALITY
Ultralife Corporation (NASDAQ) VS. ChargePoint Holdings Inc. (NYSE) • 15-METRIC TALLY: ULBI 8
— CHPT 1
▲ PIOTROSKI F-SCORE QUALITY LEADER: ULBI
LAST: $15.62 (+0.06%) • MKT CAP: $260.3M
piotroski-score
6/9
LAST: $9.27 (+0.54%) • MKT CAP: $248.9M
piotroski-score
4/9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ULBI VS. CHPT)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ULBI | CHPT | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 24.10% | 30.50% | -6.40 | CHPT | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -2.80% | -35.00% | +32.20 | ULBI | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 2.73% | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | -3.10% | -51.10% | +48.00 | ULBI | /operating-margins <GO> |
| Net Profit Margin | -3.10% | -53.50% | +50.40 | ULBI | /net-margins <GO> |
| Revenue Growth (YoY) | 16.20% | -1.40% | +17.60 | ULBI | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.71 | 0.20 | +2.51 | ULBI | /balance-sheet <GO> |
| Piotroski F-Score Quality ACTIVE | 6/9 | 4/9 | +2.00 | ULBI | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 93.4 | 62.8 | +30.68 | ULBI | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $260.3M | $248.9M | $11.4M | ULBI | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ULBI REV | CHPT REV | ULBI GROSS % | CHPT GROSS % | ULBI FCF | CHPT FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $191.2M | $411.2M | 24.1% | 30.5% | $7.1M | -$67.0M |
| FY 2024 | $164.5M | $417.1M | 25.7% | 24.1% | $14.7M | -$159.0M |
| FY 2023 | $158.6M | $506.6M | — | — | $1.9M | -$328.9M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ULBI // BETA —
CHPT // BETA —